These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Local fistula injection of allogeneic human amnion epithelial cells is safe and well tolerated in patients with refractory complex perianal Crohn's disease: a phase I open label study with long-term follow up. Keung C, Nguyen TC, Lim R, Gerstenmaier A, Sievert W, Moore GT. EBioMedicine; 2023 Dec 14; 98():104879. PubMed ID: 38042747 [Abstract] [Full Text] [Related]
18. Mesenchymal stromal cells in the treatment of perianal fistulas in Crohn's disease. Castro-Poceiro J, Fernández-Clotet A, Panés J. Immunotherapy; 2018 Oct 06; 10(14):1203-1217. PubMed ID: 30296868 [Abstract] [Full Text] [Related]
19. A Phase IB/IIA Study of Allogeneic, Bone Marrow-derived, Mesenchymal Stem Cells for the Treatment of Refractory Ileal-anal Anastomosis and Peripouch Fistulas in the Setting of Crohn's Disease of the Pouch. Lightner AL, Reese J, Ream J, Nachand D, Jia X, Pineiro AO, Dadgar N, Steele S, Hull T. J Crohns Colitis; 2023 Apr 19; 17(4):480-488. PubMed ID: 36322714 [Abstract] [Full Text] [Related]
20. Lymphoproliferative Disease in the Rectum 4 Years After Local Mesenchymal Stromal Cell Therapy for Refractory Perianal Crohn's Fistulas: A Case Report. Barnhoorn MC, Van Halteren AGS, Van Pel M, Molendijk I, Struijk AC, Jansen PM, Verspaget HW, Dijkstra G, Oosten LEM, Van der Meulen-de Jong AE. J Crohns Colitis; 2019 May 27; 13(6):807-811. PubMed ID: 30561580 [Abstract] [Full Text] [Related] Page: [Next] [New Search]